All Latest News
-
Adare Pharma Solutions Appoints Ludger Roedder as President, Adare Biome
Press Release ArchivesLawrenceville, NJ, April 20, 2021 - Adare Pharma Solutions is excited to announce that Ludger Roedder has joined the organization as President of Adare Biome. As Adare has committed to growing its Pharma Solutions and Microbiome... Learn More
-
Adare Pharma Solutions Opens New Small-Scale Laboratory to Offer Faster and More Efficient Development Capabilities to Clients
Press Release ArchivesNew laboratory brings customizable, flexible systems to expedite formulation and process development services Provides customers more early stage development capacity Lawrenceville, NJ January 26, 2021 Adare Pharma Solutions,... Learn More
-
THOMAS H. LEE PARTNERS AND FRAZIER HEALTHCARE PARTNERS ACQUIRE ADARE
Press Release ArchivesBoston, MA and Seattle, WA - September 22, 2020 Transaction includes specialty CDMO business, including pharmaceutical technology and microbiome businesses Thomas H. Lee Partners, L.P. (“THL”) and Frazier Healthcare Partners... Learn More
-
Adare Pharmaceuticals, Inc. Acquires Orbis Biosciences
Press Release ArchivesLawrenceville, NJ, and Lenexa, KS - May 4, 2020 Kansas-based pharmaceutical technology company develops customized formulations and intellectual property Deal includes platforms that can be dosed in oral, injectable and otic (ear)... Learn More
-
Adare Pharmaceuticals and NLS Pharmaceutics collaborate to develop mazindol controlled release (CR) for the treatment of ADHD and narcolepsy
Press Release ArchivesLawrenceville, NJ & Switzerland - January 13, 2020 Adare Pharmaceuticals, Inc. (Adare) and NLS Pharmaceutics Ltd. (NLS) announced today a collaboration to develop mazindol (MZD) CR product candidates for the treatment of narcolepsy... Learn More
